In the fight against cancer, scientists are always looking for new ways to make treatments work better. One big challenge is that cancer cells can become resistant to drugs over time. To tackle this, researchers have come up with a clever idea: combining two powerful tools to attack cancer cells fro
In the realm of medical advancements, a new player has entered the game: near-infrared organic nanoparticles, or 6BQ NPs for short. These tiny particles have shown promise in improving the survival rates of random flaps, a common technique used in wound repair. The challenge? Ischemic necrosis, a fa
Anorexia nervosa (AN) is a tough condition to treat. It's not just about food; it's a complex mental health issue. A new therapy called Radically Open Dialectical Behavior Therapy (RO-DBT) is trying to change that. It focuses on something called "overcontrol, " which is a big part of AN. The idea is
Ovarian cancer treatment often involves surgery followed by chemotherapy. But when should the chemo start? This is a big question. A recent study looked into this. It wanted to see how the time between surgery and chemo affects survival rates. First, the basics. Ovarian cancer is serious. Surgery i
Chronic myeloid leukemia, or CML, is a blood cancer that's defined by a specific genetic change. Doctors have been using drugs that target this change, called tyrosine kinase inhibitors, to treat CML. These drugs have been a game-changer, but some patients don't respond well and their condition wors
Doctors often use a machine to clean blood in very sick patients. This is called CRRT. Two common methods keep blood from clotting in the machine. One uses citrate. The other uses heparin. Both have pros and cons. But which one saves more money and works better? That's what experts wanted to find ou
Chordoma is a tough cancer to treat. It's rare, and doctors don't have many options. But there's a new drug called palbociclib that might help. Researchers tested palbociclib on people with advanced chordoma. They wanted to see if it could stop the cancer from growing. The results are promising. P
In a big move, Wisconsin's highest court just said the state can ban conversion therapy. This isn't just about one issue, though. It's also about who gets to make the rules in the state. The court said a group of lawmakers can't just block rules they don't like. This gives the governor more power to
IgA nephropathy is a tricky kidney problem. Doctors have a tool called the Oxford Classification to guess how it might progress. This tool looks at kidney tissue and gives scores based on certain features. But does this tool also help predict how well patients will respond to steroid treatments? Tha
Lung cancer is a serious disease. Doctors often use a mix of treatments to fight it. One common approach is neoadjuvant chemoimmunotherapy. This treatment happens before surgery. It aims to shrink tumors and make them easier to remove. But how long should this treatment last? That's a big question.
